increasing burden to health services. 3 Most patients with mild to moderate CKD are asymptomatic, but have a higher risk of cardiovascular disease and are at risk of developing anaemia, metabolic bone disease or progressing to end-stage renal disease (ESRD) requiring renal replacement therapy (RRT). 4, 5 Interventions recommended to reduce the risk of these endpoints include lifestyle modification, anti-hypertensive medication (specifically inhibitors of the renin-angiotensinaldosterone system), lipid modification, and achieving glycaemic control in patients with diabetes mellitus. 5 Patients with mild to moderate CKD are usually managed within primary care and referred to specialist care as the condition progresses. 6 However, efforts to increase the awareness of CKD have led to the identification of large numbers of patients with mild to moderate CKD, creating challenges in the design and delivery of health services. 5 How health services should be organized to support patients with CKD most effectively is unclear. 5, 7 The existing literature on interventions to improve outcomes in CKD is of predominantly individual interventions, for example, psychological support, pharmacist medication review, anti-hypertensive medication. [8] [9] [10] In clinical practice, many individual interventions are used together for an individual patient. This multidimensional approach, grouping packages of interventions forms a 'model of care'. Understanding the optimal model of care for CKD patients is important and would allow the design of health services to maximize health and well-being whilst making the best use of limited resources. 11 In this systematic review, we assessed the relative effectiveness of different models of care for the management of CKD for a range of outcomes.
METHODS Data sources and searches
Cochrane methodology was followed, with the exception that only one reviewer screened titles of publications identified from searches. Electronic searches were performed to identify articles published between 1992 and October 2014, and updated through to June 2016. A search strategy was developed for MEDLINE, and adapted for seven other databases (File S1), which was constructed to be highly sensitive to take into account the lack of consistent terminology to identify models of care studies. The reference lists of included articles and any systematic reviews identified from the searches were also checked. All citations were downloaded to REFWORKS Reference Management Software (Version 2.0). Titles were screened by one author (LR, RN, EG or CB). Abstracts and full text were screened independently by two authors (LR, RN, EG, CB, AM or PS). Any disagreements were resolved by discussion and consensus.
Study selection
Studies were included which compared any two multidimensional models of care in adults with pre-dialysis CKD and reported any of a defined list of outcomes. We included randomized controlled trials (RCTs), published in English from 1992 onwards (10 years prior to the KDIGO CKD guidelines). 6 We excluded observational studies in order to limit the potential for bias. For this review, a model of care must have been capable of delivering more than one type of intervention targeted at more than one aspect of disease management.
Data extraction and quality assessment
Standardized data extraction forms were developed. Data extraction was carried out independently by two authors and any disagreements were resolved through discussion and consensus. Data collected included setting, population details, quality assessment items, details of the intervention, model of care and comparison management details, and outcomes of interest. Quality assessment was carried out using the Cochrane Collaboration's 'Risk of Bias' tool, without modification. 12 This uses pre-specified grading criteria to categorize the degree of risk as either low, unclear or high for multiple domains. The highest degree of risk for any of these domains is then used to determine the overall risk of bias. Risk of bias was assessed independently by two reviewers and any differences were resolved by consensus.
Outcomes
Outcomes of interest included clinical endpoints (progression of CKD, progression to ESRD without RRT, initiation of RRT, cardiovascular endpoints, mortality), management of risk factors (blood pressure, weight, anaemia, bone disease), prescribing of relevant medications, patient education, quality of life, health service satisfaction, health service use and health service costs.
Data synthesis and analysis
Study results were tabulated and reported qualitatively. Due to high levels of heterogeneity we were unable to perform a meta-analysis.
RESULTS
The searches identified 8672 citations (Fig. 1 ). After removal of duplicates, title screening and abstract screening, 58 articles remained. Following full text review, nine articles (seven studies) were deemed to meet the eligibility criteria and were included. Two trials were conducted in the Netherlands, two in the USA, one in Canada, one in China, and one in Taiwan. The characteristics of the included studies are shown in Table S1 .
Description of studies and interventions
Studies were categorized according to the model of care assessed (Table 1) . Three examined nurse-led care, 13-17 two examined multi-disciplinary specialist care, 18, 19 one examined pharmacist care 20 and one examined a form of patient selfmanagement care termed 'self-management support. 21 Study cohorts ranged in size from 54 to 2199 participants. In the studies examining nurse-led care and multi-disciplinary specialist care, the intervention was compared against 'usual care' for the respective setting. However, in the studies examining pharmacist care and self-management support, these interventions were delivered in addition to usual care. The follow-up period for most studies was typically less than 2 years, with the exception of the MASTERPLAN study [13] [14] [15] examining nurse-led care, which had a mean follow-up of 5.7 years and Harris et al.
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examining multi-disciplinary specialist care, which had a 5 year follow-up period. A common feature to all of the models of care described in the studies was an increased emphasis on treatment that adhered to a standardized protocol or guideline.
Nurse-led care
In the MASTERPLAN study, [13] [14] [15] the intervention group received care delivered by specialist nurses working in secondary care under the supervision of nephrologists whilst the control group received nephrologist care. In Scherpbier de Haan et al., 16 the intervention group received care delivered by nurse practitioners in a primary care setting under the supervision of General Practitioners (GPs), whilst the control group received usual care from GPs with the assistance of nurse practitioners. In Barrett et al., 17 the intervention group received care led by nurses in primary care who could request assistance of GPs or nephrologists, as required, whilst the control group received usual care led by GPs.
Multidisciplinary specialist care
In Chan et al., 18 the intervention group received structured multidisciplinary care from a diabetologist, endocrine trainees, diabetic nurses and a dietician in a secondary care setting whilst the control group received usual care as led by a diabetologist or general physician. In Harris et al., 19 the Articles identified through database searching ( (n = 8667)
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Full-text articles excluded, with reasons (n = 49) 8 cohort studies 4 abstracts 2 description of services 1 dialysis patients 13 non-randomized studies 5 not models of care 1 chart review 5 single dimension of care 2 reviews 7 systematic reviews 1 protocol Studies included in systematic review n = 7 (9 articles) Fig. 1 Flow diagram of search and study selection process intervention group received structured multidisciplinary care from a nephrologist, renal nurse, dietician and social worker in a secondary care setting whilst those in the control group received usual care from GPs with other health professional input if requested.
Pharmacist care
In Cooney et al., 20 the intervention group received pharmacy care input prior to previously arranged GP appointments whilst the control group received usual GP care only.
Self-management
In Chen et al., 21 the intervention group participated in an intensive multidisciplinary programme to support selfmanagement alongside usual nephrologist care whilst the control group received usual nephrologist care only.
Risk of bias
Using the Cochrane assessment of bias tool, all included studies were classified as having high risk of bias, primarily because participants and personnel were not blinded in any of the studies although this would have been difficult due to the type of intervention being assessed (Table S2) . When blinding was removed as a key domain, five out of seven studies remained at high risk of bias with the other two at unclear risk of bias. In three studies, the randomization process was not described clearly. Sealed envelopes were used to conceal allocation status in one study 18 and in the remaining studies allocation concealment was either not described or not performed. Blinding of outcome assessment was clearly described in only three studies. Outcome reporting was incomplete in three studies. In two of these studies the reasons for losses to follow-up were not clear 19, 21 and in the third the authors reported higher rates of use of drugs blocking the renin-angiotensin-aldosterone system but do not report the data to support this. 16 The potential for selective reporting was present or unclear in six studies as the original study protocol was unavailable (86%). Other sources of bias identified included the potential for recruitment bias in one study, 17 lack of assessment to protocol adherence, 17 and anomalies in the way patient flow was described. 21 Outcomes
Renal
All seven studies reported renal outcomes (Table 2) . Of the three studies investigating nurse-led care, one reported a small statistically significant reduction in mean rate of decline in eGFR in the intervention group (1.26 vs. 1.71 mL/min per 1.73 m 2 per year, P = 0.01, mean follow-up 5.7 years). [13] [14] [15] However, in the same study there Intervention provided in addition to usual care (equivalent to the comparator group).
✓ included, ✕ not included. CKD, chronic kidney disease; GP, general practitioner.
was no statistically significant difference in the number of reported ESRD events or the number of patients with greater than 50% rise in serum creatinine. The remaining two studies found no effect of nurse-led care on renal outcomes. 16, 17 Two studies investigated multidisciplinary specialist care and found no effect on renal outcomes. 18, 19 One study investigating pharmacist care found no effect on renal outcomes. 20 One small study investigating self-management support found that the absolute eGFR was higher in the intervention group after one year (29.1 vs. 15.7 mL/min per 1.73 m 2 , P = 0.04) and that the number of patients with a greater than 50% decline in eGFR was lower (1 vs. 9, P < 0.05). However, there was a non-significant difference in mean eGFR at baseline and there was no difference in the number of patients who progressed to requiring RRT. 21 
Cardiovascular
Two studies reported cardiovascular outcomes. The MAS-TERPLAN study [13] [14] [15] which investigated nurse led care found no significant difference between groups for the composite cardiovascular (HR 0.90, 95% CI 0.58-1.39) or composite ischaemic heart disease endpoint (HR 1.15, 95% CI 0.71-1.86). Chan et al. 18 which investigated multidisciplinary specialist care found no significant difference between groups for their composite cardiovascular endpoint.
Mortality
Five studies reported mortality rates (Table 3) . None found any significant difference in mortality between intervention and comparator models of care. 
Blood pressure
Five studies reported blood pressure outcomes (Table S3) . Three of these studies investigated nurse-led care. One found a statistically significant reduction in final mean systolic (134 vs. 136 mmHg) and diastolic (77 vs. 79 mmHg) blood pressure in the intervention group. [13] [14] [15] One found a statistically significant increase in the number of patients with systolic blood pressure < 130 mmHg (44.4% vs. 21.6%) and diastolic blood pressure < 80 mmHg (71.1% vs. 50.0%) at 1 year. 16 However, the third found no significant improvement in blood pressure control. 17 One study investigated multi-disciplinary specialist care and found a statistically significant increase in the proportion of patients achieving a blood pressure < 130/80 mmHg (49% vs. 27%). 18 One study investigated pharmacist care and found no significant difference in blood pressure outcomes. 20 
Prescribing
Six studies reported drug prescribing rates (Table S4) . Three investigated nurse-led care and all demonstrated statistically significant increases in the prescribing of relevant drugs. These included ACE inhibitors, [13] [14] [15] [16] lipid-modifying agents, [13] [14] [15] [16] [17] Aspirin, [13] [14] [15] Vitamin D, [13] [14] [15] [16] and iron supplements. 17 There was no significant difference in the rate of prescribing for phosphate binders. [13] [14] [15] Two studies investigated multidisciplinary specialist care. One demonstrated no significant difference in rates of prescribing. 19 The other demonstrated a significantly higher rate of prescribing for ACE inhibitors although this was also present at baseline. 18 One study investigated pharmacist care and demonstrated a significantly higher rate of prescribing for Vitamin D and bicarbonate at the end of the study but this was not demonstrated for phosphate binders or ACE inhibitors. 20 
Body mass index and weight
Three studies reported body mass index (BMI) or weight (Table S5) . None demonstrated any significant improvement in weight or BMI.
Health service use and costs
Three studies reported on health service use (Table S5) . One study investigating nurse-led care found that whilst the mean number of total visits (including nurse visits) per year was higher in the intervention group (7.0 vs. 4.7, P < 0.001), the mean number of physician visits per year was lower (2.8 vs. 3.7, P < 0.001). Although the study was not designed to include a cost-benefit analysis, a crude estimate of costs and savings is reported as a supplement. [13] [14] [15] One study investigating multidisciplinary specialist care found that the mean total number of outpatient clinic visits at 3-5 years was higher in the intervention group (26.0 vs. 18.0, P < 0.001) but demonstrated no difference in the number of hospitalizations or emergency department visits. The annual direct costs of the intervention were reported as $484 per intervention patient. 19 One small study investigating self-management support found the total number of hospitalizations at 12 months was significantly lower in the intervention group (5 vs. 12, P < 0.05). 21 
Patient education
One study investigating self-management support found a statistically significant increase in patient education status using a standardized CKD knowledge score in the intervention group at 1 year (10.13 vs. 5.51, P < 0.01).
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Quality of life
One study investigating pharmacist care found no significant difference between intervention and comparator model of care with regards to quality of life outcomes. 20 
Patient satisfaction
Two studies reported on satisfaction with care, but only in the intervention group. Both reported high satisfaction with care received.
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DISCUSSION
To our knowledge, this is the first systematic review of RCTs of the effectiveness of different models of care for CKD against a range of outcomes. The seven studies included in this review evaluated four different categories of models of care. Those examining nurse-led care and multi-disciplinary specialist care compared these models of care against usual care, whereas in those examining pharmacist-care and selfmanagement support, the interventions were delivered in addition to usual care. Although the majority of studies did not find a significant effect on outcomes, there was some evidence of improved short term clinical outcomes (e.g. blood pressure) and care utilization outcomes (e.g. prescribing). This was particularly true where models of care were protocol-driven through nurse-and pharmacist-led approaches. There was little evidence that these improvements translated into improvements in the rates of key clinical outcomes, including renal, cardiovascular or mortality endpoints. However, these were not reported in all studies with only two studies reporting cardiovascular outcomes and five reporting mortality. Furthermore, only two studies followed patients for more than 2 years and had statistical power calculations performed to ensure they were of sufficient size to detect a difference.
With regard to non-clinical outcomes, there was some evidence that nurse-led care led to a reduced number of physician visits, although this was necessarily associated with an increased number of nurse visits. The only study to investigate the addition of self-management support to usual care found a clinically and statistically significant reduction in the rate of hospital admissions in the intervention group. However, as this was a small study, the results should be treated with caution until replicated in a larger population.
Although there was significant heterogeneity between studies, there were common elements between studies and between different categories of model of care. In the majority of studies there was an increased use of either nursing or allied health professionals to deliver care. In addition, in the majority of studies, health professionals used a structured protocol or guideline focused on specific treatment targets to help them deliver care. This may explain why improvements in some outcomes were noted across different categories of models of care. There may also be variation with regard to country, setting, clinical practice, resources and practitioners' roles, for example, qualified to prescribe or otherwise.
Other reviews of CKD models of care have included observational studies alongside RCTs. One review investigated multidisciplinary care in the management of CKD and found some evidence of improved renal and metabolic outcomes. 22 However, this systematic review included four studies, two of which were observational, and the majority of the positive findings were derived from the nonrandomized observational studies. Of the two RCTs within this review, one was included within our review 19 and the other was excluded as it did not meet our definition of a multidimensional model of care. 23 Another review investigated pharmacist interventions in the management of CKD. 24 Most of the studies included were observational but it found some evidence that pharmacist interventions led to improved prescribing and metabolic outcomes. None of these studies met the inclusion criteria for our review. Our study has many strengths. With the exception of the initial title-screening, all parts of the selection process, quality assessment and data extraction were performed independently by two reviewers to limit the potential for bias. Eight databases were searched using a highly sensitive search strategy to take account of the lack of consistent terminology to identify models of care studies. The search was restricted to RCTs to limit the potential for bias. 25 However, there are study limitations. Although the search strategy was chosen to maximize sensitivity there may be relevant published studies not identified by our searches. Unpublished studies were not included, which may leave the review at risk of reporting bias. In addition, restricting the review to only include RCTs meant that any good quality observational studies were not included. The RCTs identified, however, were all classified as having a high risk of bias. Despite the increasing recognition of the importance of identifying effective models of care for patients with longterm conditions such as CKD, there was little published evidence to guide best practice for service design. 26 This review identified only seven studies assessing four different multidimensional models of care between them. One potential reason may be perceived difficulty in designing studies to assess complex interventions. However, there are solutions including use of cluster RCTs and stepped wedge designs. 25 When a model of care is identified as improving outcomes, it is important to carefully define the intervention and identify which elements of care are responsible as this allows designers to improve services with minimal change. Models of care should be evaluated as complex interventions including the emerging approaches to shared care. 25 In conclusion despite the growing burden from CKD, there was little published evidence about the effectiveness of different models of care to guide best practice for service design. There was limited evidence, from studies classified as having a high risk of bias, that models of care where nurses or allied health professionals deliver care according to a structured protocol or guidelines may improve adherence to treatment targets; and also that self-management may reduce hospitalizations. In order to drive future policy recommendations, a multi-centre RCT of a highly protocolized model of care versus usual care that randomized on centre (considering a step-wedge methodology if necessary), with long follow-up of at least 5 years to allow assessment of hard outcomes such as mortality, readmission and health service use in addition to short-term process related outcomes such as BP, and of sufficient size is required. To aid intervention design for future RCTs, a review of observational studies is recommended.
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